Lansing TJ - Search Results

1

Monoclonal antibodies generated against recombinant ATM support kinase activity.

Alligood KJ, Milla M, Rhodes N, Ellis B, Kilpatrick KE, Lee A, Gilmer TM, Lansing TJ. Alligood KJ, et al. Among authors: lansing tj. Hybridoma. 2000 Aug;19(4):317-21. doi: 10.1089/027245700429864. Hybridoma. 2000. PMID: 11001404

2

Expression and purification of active recombinant ATM protein from transiently transfected mammalian cells.

Rhodes N, Gilmer TM, Lansing TJ. Rhodes N, et al. Among authors: lansing tj. Protein Expr Purif. 2001 Aug;22(3):462-6. doi: 10.1006/prep.2001.1459. Protein Expr Purif. 2001. PMID: 11483009

3

A simple method for predicting serum protein binding of compounds from IC(50) shift analysis for in vitro assays.

Rusnak DW, Lai Z, Lansing TJ, Rhodes N, Gilmer TM, Copeland RA. Rusnak DW, et al. Among authors: lansing tj. Bioorg Med Chem Lett. 2004 May 3;14(9):2309-12. doi: 10.1016/j.bmcl.2004.01.103. Bioorg Med Chem Lett. 2004. PMID: 15081030

4

Involvement of pp60c-src with two major signaling pathways in human breast cancer.

Luttrell DK, Lee A, Lansing TJ, Crosby RM, Jung KD, Willard D, Luther M, Rodriguez M, Berman J, Gilmer TM. Luttrell DK, et al. Among authors: lansing tj. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):83-7. doi: 10.1073/pnas.91.1.83. Proc Natl Acad Sci U S A. 1994. PMID: 7506422 Free PMC article.

5

Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.

Lansing TJ, Turk BF, Kanner SB, Gilmer TM. Lansing TJ, et al. Cancer Res. 1997 May 15;57(10):1962-9. Cancer Res. 1997. PMID: 9157992

6

In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1.

Lansing TJ, McConnell RT, Duckett DR, Spehar GM, Knick VB, Hassler DF, Noro N, Furuta M, Emmitte KA, Gilmer TM, Mook RA Jr, Cheung M. Lansing TJ, et al. Mol Cancer Ther. 2007 Feb;6(2):450-9. doi: 10.1158/1535-7163.MCT-06-0543. Epub 2007 Jan 31. Mol Cancer Ther. 2007. PMID: 17267659

7

Characterization of human Gadd45, a p53-regulated protein.

Carrier F, Smith ML, Bae I, Kilpatrick KE, Lansing TJ, Chen CY, Engelstein M, Friend SH, Henner WD, Gilmer TM, et al. Carrier F, et al. Among authors: lansing tj. J Biol Chem. 1994 Dec 23;269(51):32672-7. J Biol Chem. 1994. PMID: 7798274 Free article.

8

The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization.

Goldman SC, Chen CY, Lansing TJ, Gilmer TM, Kastan MB. Goldman SC, et al. Among authors: lansing tj. Am J Pathol. 1996 May;148(5):1381-5. Am J Pathol. 1996. PMID: 8623910 Free PMC article.

9

Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity.

Rhodes N, Heerding DA, Duckett DR, Eberwein DJ, Knick VB, Lansing TJ, McConnell RT, Gilmer TM, Zhang SY, Robell K, Kahana JA, Geske RS, Kleymenova EV, Choudhry AE, Lai Z, Leber JD, Minthorn EA, Strum SL, Wood ER, Huang PS, Copeland RA, Kumar R. Rhodes N, et al. Among authors: lansing tj. Cancer Res. 2008 Apr 1;68(7):2366-74. doi: 10.1158/0008-5472.CAN-07-5783. Cancer Res. 2008. PMID: 18381444

10

Separate pathways for p53 induction by ionizing radiation and N-(phosphonoacetyl)-L-aspartate.

Chen CY, Hall I, Lansing TJ, Gilmer TM, Tlsty TD, Kastan MB. Chen CY, et al. Among authors: lansing tj. Cancer Res. 1996 Aug 15;56(16):3659-62. Cancer Res. 1996. PMID: 8706003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page